Pasadena’s EvoRx Technologies Completes Year-long Collaboration with Major Global Biopharmaceutical

first_img faithfernandez More » ShareTweetShare on Google+Pin on PinterestSend with WhatsApp,Virtual Schools PasadenaHomes Solve Community/Gov/Pub SafetyCitizen Service CenterPASADENA EVENTS & ACTIVITIES CALENDARClick here for Movie Showtimes Home of the Week: Unique Pasadena Home Located on Madeline Drive, Pasadena 8 recommended0 commentsShareShareTweetSharePin it EVENTS & ENTERTAINMENT | FOOD & DRINK | THE ARTS | REAL ESTATE | HOME & GARDEN | WELLNESS | SOCIAL SCENE | GETAWAYS | PARENTS & KIDS Name (required)  Mail (required) (not be published)  Website  Business News Pasadena Will Allow Vaccinated People to Go Without Masks in Most Settings Starting on Tuesday Pasadena’s ‘626 Day’ Aims to Celebrate City, Boost Local Economy More Cool Stuff Pasadena-based biotechnology company EvoRx Technologies has completed a year-long research collaboration with the global biopharmaceutical firm AstraZeneca aimed at improving drug delivery to treat patients with diseases that have not been accessible with traditional strategies.The collaboration leveraged EvoRx’s proprietary Evo-Link technology which aims to rapidly develop more potent and cell permeable peptide compounds that can be orally administered to treat patients especially with respiratory diseases.At the end of the research work, EvoRx reported that their team had successfully generated peptides that could eventually result in a more potent drug-delivery process, which is the primarily goal of the collaboration.“This collaboration allowed us to further validate our unique approach in successfully targeting intracellular protein-protein interactions thought to be undruggable,” Stephen Fiacco, EvoRx CEO, said. “Our new therapeutic paradigm has the potential to be a game changer for many patients with diseases that so far have not been accessible with traditional strategies in drug discovery. This opens the door for novel treatment across many therapeutic areas.”EvoRx said nearly 70 percent of proteins implicated in diseases are considered “undruggable,” or inaccessible to drugs using traditional treatment approaches. The company’s Evo-Link technology seeks to address this deficiency.Dr. Maarten Kraan, head of the Respiratory, Inflammation and Autoimmune Diseases Innovative Medicines Unit at AstraZeneca, said they were able to make “very significant progress on the permeability problem” of their peptides with the collaboration with EvoRx.“Many disease targets are intractable to both small molecule and biologic therapy, limiting our options to discover new treatments for these life-threatening and debilitating diseases,” Kraan said. “Designing potent, stable, cell penetrating peptides is also one of our industry’s biggest challenges, and so we are delighted with the outcome of our collaboration with EvoRx Technologies.”AstraZeneca will continue to develop the cell-penetrating peptides after the end of the collaboration.EvoRx, with offices and laboratories at 129 N. Hill Avenue in Pasadena, is a privately held company founded in 2011 which strives to develop innovative peptide therapeutics and targeted radiopharmaceuticals for treatment and diagnosis of diseases.More information about the company and its work is available at their website, www.evorxtechnologies.com. Top of the News center_img Community News First Heatwave Expected Next Week Community News Company News Briefs Pasadena’s EvoRx Technologies Completes Year-long Collaboration with Major Global Biopharmaceutical From STAFF REPORTS Published on Thursday, July 9, 2015 | 12:52 pm Your email address will not be published. Required fields are marked * Get our daily Pasadena newspaper in your email box. Free.Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m. Make a comment Subscribe HerbeautyShort On Time? 10-Minute Workouts Are Just What You NeedHerbeautyHerbeautyHerbeautyWeird Types Of Massage Not Everyone Dares To TryHerbeautyHerbeautyHerbeautyWant To Seriously Cut On Sugar? You Need To Know A Few TricksHerbeautyHerbeautyHerbeauty6 Strong Female TV Characters Who Deserve To Have A SpinoffHerbeautyHerbeautyHerbeautyWho Was The Hollywood ‘It Girl’ The Year You Were Born?HerbeautyHerbeautyHerbeauty15 Countries Where Men Have Difficulties Finding A WifeHerbeautyHerbeautylast_img read more

Continue Reading

Thunder’s Russell Westbrook extends triple-double record to 11 games

first_img FacebookTwitterLinkedInEmailAllen Kee / ESPN Images(NEW ORLEANS) — Oklahoma City Thunder’s Russell Westbrook extended his NBA record of consecutive triple-doubles to 11 games Thursday.The 30-year-old point guard finished the night with 44 points, 14 rebounds and 11 assists, but it wasn’t enough to help his team fend off the New Orleans Pelicans, who won 131-122.Earlier this week, Westbrook broke Wilt Chamberlain’s record of nine consecutive triple-doubles, set back in 1968.So far this season, Westbrook leads the NBA with 24 triple-doubles.Copyright © 2019, ABC Radio. All rights reserved. Written by February 15, 2019 /Sports News – National Thunder’s Russell Westbrook extends triple-double record to 11 gamescenter_img Beau Lundlast_img read more

Continue Reading